2025. Development and Optimization of Acyl Chitosan-Based SNEDDS for Enhanced Oral Bioavailability of Lipophilic Drugs. Current Pharmaceutical Letters And Reviews. 2, 1 (Nov. 2025), 09–18. DOI:https://doi.org/10.62896/cplr.2.1.09.